{
  "retracted": false,
  "timestamp": 1543968000000,
  "updates": [
    {
      "timestamp": 1550530418049,
      "identifier": {
        "doi": "10.1007/s13300-018-0543-9"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s13300-018-0456-7"
  },
  "journal": "Diabetes Therapy",
  "publisher": "Springer Nature",
  "title": "Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons"
}
